At a glance
ClinicalIndex Comparison RecordN/ACompleted· 67,028 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Improving Care for Cardiovascular Disease in China: A Collaborative Project of AHA and CSC (CCC Project) - Atrial Fibrillation
Beijing Institute of Heart, Lung and Blood Vessel Diseases·observational·Posted Dec 5, 2014·Updated Jan 27, 2021
In Brief
An observational study for Atrial Fibrillation. Completed, enrolled 67,028 participants across 1 site.
Detailed Summary
The purpose of this study is to develop and implement quality improvement programs for the treatment of atrial fibrillation (AF) in China based on the successful experience of the AHA-Get with the Guidelines program. This program will use data collection, analysis, feedback, and process improvement to extend the use of evidence-based guidelines throughout the healthcare system and improve patient care of atrial fibrillation.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesChina
CollaboratorsAmerican Heart Association, Chinese Society of Cardiology
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 2014
Enrollment StartJan 2015
Primary CompletionDec 2020
TodayJul 2026
First PostedDec 5, 2014
Enrollment StartJan 1, 2015
Primary CompletionDec 1, 2020
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 11.6 years ago